Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

How Private Equity Oversees the Ethics of Drug Research

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.

Walt Bogdanich
Author: Walt Bogdanich

Written by

Walt Bogdanich

in

Clinical Trials, Conflicts of Interest, Drugs (Pharmaceuticals), Ethics and Official Misconduct, GLP-1 RAs (Drug), Mergers, Acquisitions and Divestitures, Novo Nordisk A/S, Ozempic (Drug), Private Equity, Regulation and Deregulation of Industry, Research
←An American Way of Dress
More Retirees Are Living on Less, and Losing a Means of Help to Pay for Medicare→

More posts

  • Bob Iger’s New Magic Kingdom: Fans & Media Wonder If He Can Bring That Disney Sparkle To The Lakers

  • Photos: See the best photos from the solar eclipse

  • Ebola outbreak on track to be deadliest ever, WHO chief says

  • Jeremy Strong Emailed Mark Zuckerberg To Assure Him He Takes ‘The Social Reckoning’ Role “Very Seriously”

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube